Dong‐Wook Kim

机构：Eulji University, The Catholic University of Korea Uijeongbu St. Mary's Hospital, Eulji University Uijeongbu Eulji Medical Center · ORCID：0000-0003-3967-4267

发表论文 607 篇 · 总被引 22827 次 · h-index 65

代表论文

• 2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia (2025 · Leukemia · 被引 110)
• Asciminib monotherapy in patients with chronic myeloid leukemia in chronic phase without BCR::ABL1T315I treated with at least 2 prior TKIs: Phase 1 final results (2025 · Leukemia · 被引 12)
• Asciminib remained superior vs bosutinib in late-line CML-CP after nearly 4 years of follow-up in ASCEMBL (2025 · Blood Advances · 被引 11)
• Vodobatinib for patients with Philadelphia chromosome-positive chronic myeloid leukaemia resistant or intolerant to multiple lines of previous therapy: an open-label, multicentre, phase 1/2 trial (2025 · The Lancet Haematology · 被引 9)
• Asciminib (ASC) Demonstrates Favorable Safety and Tolerability Compared with Each Investigator-Selected Tyrosine Kinase Inhibitor (IS TKI) in Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) in the Pivotal Phase 3 ASC4FIRST Study (2024 · Blood · 被引 7)
• Regulation of metabolic adaptation and leukemia progression by MUSASHI2-DEPTOR-KIF11 axis (2025 · Leukemia · 被引 3)